Clinical Trial Update: Dose-finding Study Using Pentostatin for Injection in the Treatment of Steroid-refractory aGvHD [Phase 1, Phase 2]

View source ↗

Summary

Update on a Phase 1/2 dose-finding trial of pentostatin for injection for steroid-refractory acute graft-versus-host disease; the study is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Pentostatin for Injection (pentostatin)

Snippet

Sponsor: Astex Pharmaceuticals, Inc. | Conditions: Acute Graft Versus Host Disease | Phase 1, Phase 2 | Status: TERMINATED